节点文献

厄贝沙坦与吲达帕胺联合治疗中、重度高血压的疗效观察

Irbesartan plus indapamide for hypertension

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 殷安康

【Author】 YIN An-kang.Yangzhou No.4 People’s Hospital,Yangzhou Jiangsu 225002,China

【机构】 扬州市第四人民医院五病区 江苏扬州225002

【摘要】 目的研究厄贝沙坦与吲哒帕胺合用治疗中、重度高血压的疗效。方法60例中、重度高血压患者厄贝沙坦150mg,每日1次,加吲哒帕胺2.5mg每日1次,连续8周。用药前后监测血压、心率、血钾、肾功能、血糖及血脂。结果治疗后血压有明显下降总有效率96.67%,治疗后总胆固醇(TC)、三酰甘油(TG)较治疗前均有升高趋势,但无统计学意义(P>0.05)。治疗后患者的血钾有降低,但无1例发生低钾血症。治疗后患者的血糖(BG)、血尿素氮(BUN)、血肌酐(Cr)较治疗前无明显变化。结论厄贝沙坦与吲哒帕胺联合治疗中、重度高血压疗效显著,副作用少,且两者价格便宜,值得推广使用。

【Abstract】 Objective To investigate the effectiveness of irbesartan plus indapamide for hypertension.Methods 60 patients with mild or moderate hypertension were treated with irbesartan(150 mg once daily)plus indapamide(2.5 mg once daily)for 8 weeks.Blood pressure,heart rate,serum potassium,renal function,blood sugar and blood lipid were tested before and after treatment.Results Blood pressure decreased significantly after treatment,with the overall response rate being 96.67%.Total cholesterol and triglyceride showed a tendency to increase after treatment,but the differences was not statistically significant(P>0.05).Serum potassium level decreased after treatment,but did not reach hypopotassemic level.There were no significant changes in blood sugar,blood urea nitrogen and serum creatinine after treatment.Conclusion The therapeutic results of irbesartan plus indapamide for mild and moderate hypertension are good,with few complications deserving recommendation.

【关键词】 高血压厄贝沙坦吲哒帕胺
【Key words】 HypertensionIrbesartanIndapamide
  • 【文献出处】 临床和实验医学杂志 ,Journal of Clinical and Experimental Medicine , 编辑部邮箱 ,2007年09期
  • 【分类号】R544.1
  • 【被引频次】2
  • 【下载频次】52
节点文献中: 

本文链接的文献网络图示:

本文的引文网络